UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer

Journal of clinical oncology, 1992-11, Vol.10 (11), p.1754-1761

1992

Volltextzugriff (PDF)

Primary central nervous system non-hodgkin's lymphoma: Survival advantages with combined initial therapy?

International journal of radiation oncology, biology, physics, 1995-10, Vol.33 (3), p.663-673

1995

Volltextzugriff (PDF)

A 10 kPixel CMOS Hall Sensor Array With Baseline Suppression and Parallel Readout for Immunoassays

IEEE journal of solid-state circuits, 2013-01, Vol.48 (1), p.302-317

2013

Volltextzugriff (PDF)

Primary central nervous system non-hodgkin’s lymphoma (PCNSL): survival advantages with combined initial therapy? a final report of the north central cancer treatment group (NCCTG) study 86-72-52

International journal of radiation oncology, biology, physics, 1999-02, Vol.43 (3), p.559-563

1999

Volltextzugriff (PDF)

Metabolic characterization of human non-Hodgkin's lymphomas in vivo with the use of proton-decoupled phosphorus magnetic resonance spectroscopy

Cancer research (Chicago, Ill.), 1995-08, Vol.55 (15), p.3286-3294

1995

Volltextzugriff (PDF)

A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: An Eastern Cooperative Oncology Group study (PZ586)

Lung cancer, 1999-09, Vol.25 (3), p.199-206

1999

Volltextzugriff (PDF)

Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer

Journal of clinical oncology, 1994-06, Vol.12 (6), p.1251-1258

1994

Volltextzugriff (PDF)

Thrombocytopenia in homosexual patients. Prognosis, response to therapy, and prevalence of antibody to the retrovirus associated with the acquired immunodeficiency syndrome

Annals of internal medicine, 1985-10, Vol.103 (4), p.542

1985

Volltextzugriff (PDF)

Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine

Journal of clinical oncology, 1984-10, Vol.2 (10), p.1115-1120

1984

Volltextzugriff (PDF)

A CMOS 10kpixel baseline-free magnetic bead detector with column-parallel readout for miniaturized immunoassays

2012 IEEE International Solid-State Circuits Conference, 2012, p.126-128

2012

Volltextzugriff (PDF)

High-dose therapy with stem cell infusion in lymphoma

Seminars in oncology, 1995-06, Vol.22 (3), p.218-229

1995

Volltextzugriff (PDF)

Prognostic factors and staging classification of patients with epidemic Kaposi's sarcoma

Journal of clinical oncology, 1989-06, Vol.7 (6), p.774-780

1989

Volltextzugriff (PDF)

Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon

Journal of clinical oncology, 1990-03, Vol.8 (3), p.460-467

1990

Volltextzugriff (PDF)

Phase I evaluation of combination therapy with interleukin 2 and γ-interferon

Cancer research (Chicago, Ill.), 1991-08, Vol.51 (15), p.3910-3918

1991

Volltextzugriff (PDF)

A phase I study of recombinant interleukin 2 plus recombinant β-interferon

Cancer research (Chicago, Ill.), 1988-07, Vol.48 (13), p.3875-3881

1988

Volltextzugriff (PDF)

Hoarseness ; a unique clinical presentation for renal cell carcinoma

Urology (Ridgewood, N.J.), 1992-08, Vol.40 (2), p.159-161

1992

Volltextzugriff (PDF)

Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancer

Seminars in oncology, 1994-06, Vol.21 (3 Suppl 4), p.6-11

1994

Volltextzugriff (PDF)

Reversible neurotoxicity due to oral acyclovir in a patient with chronic lymphocytic leukemia

The Journal of infectious diseases, 1986-07, Vol.154 (1), p.189

Krigel, R L

1986

Volltextzugriff (PDF)

Phase I study of sequentially administered recombinant tumor necrosis factor and recombinant interleukin-2

Journal of immunotherapy with emphasis on tumor immunology, 1995-04, Vol.17 (3), p.161

1995

Volltextzugriff (PDF)

The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: cognitive function and performance status. North Central Cancer Treatment Group

Neuro-oncology (Charlottesville, Va.), 1999-07, Vol.1 (3), p.196-203

1999

Volltextzugriff (PDF)

Kaposi sarcoma and alpha-interferon therapy

Annals of internal medicine, 1989-07, Vol.111 (2), p.185

Krigel, R L

1989

Volltextzugriff (PDF)

Hemorrhagic Gastritis as a New Dose-Limiting Toxicity of Recombinant Tumor Necrosis Factor

JNCI : Journal of the National Cancer Institute, 1991-01, Vol.83 (2), p.129-129

1991

Volltextzugriff (PDF)

A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinoma

Investigational new drugs, 1995-01, Vol.13 (3), p.241-247

1995

Volltextzugriff (PDF)

A Phase I study of WR-2721 in combination with total body irradiation (TBI) in patients with refractory lymphoid malignancies

International Journal of Radiation Oncology, Biology, & Physics [INT. J. RADIAT. ONCOL. BIOL. PHYS.]. Vol. 22, no. 4. 1992, 1992, Vol.22 (4), p.791-794

1992

Volltextzugriff (PDF)

Metastatic extramedullary plasmacytoma: A case report and review of the literature of a rare pseudocarcinoma

American journal of hematology, 1988-02, Vol.27 (2), p.115-117

1988

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(53)
Tagungsberichte
(2)

Sprache

Englisch
(55)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(41)
Science & Technology
(39)
Life Sciences & Biomedicine
(36)
Male
(28)
Middle Aged
(26)
Oncology
(25)
Adult
(23)
Female
(20)
Aged
(19)
Biological And Medical Sciences
(19)
Medical Sciences
(19)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Pharmacology. Drug Treatments
(10)
Antineoplastic Agents
(9)
Combined Modality Therapy
(7)
Immunotherapy
(7)
Aids/hiv
(6)
Immunology
(6)
Interferon Type I - Therapeutic Use
(6)
Interleukin-2 - Administration & Dosage
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer

Primary central nervous system non-hodgkin's lymphoma: Survival advantages with combined initial therapy?

A 10 kPixel CMOS Hall Sensor Array With Baseline Suppression and Parallel Readout for Immunoassays

Primary central nervous system non-hodgkin’s lymphoma (PCNSL): survival advantages with combined initial therapy? a final report of the north central cancer treatment group (NCCTG) study 86-72-52

Metabolic characterization of human non-Hodgkin's lymphomas in vivo with the use of proton-decoupled phosphorus magnetic resonance spectroscopy

A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: An Eastern Cooperative Oncology Group study (PZ586)

Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer

Thrombocytopenia in homosexual patients. Prognosis, response to therapy, and prevalence of antibody to the retrovirus associated with the acquired immunodeficiency syndrome

Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine

A CMOS 10kpixel baseline-free magnetic bead detector with column-parallel readout for miniaturized immunoassays

High-dose therapy with stem cell infusion in lymphoma

Prognostic factors and staging classification of patients with epidemic Kaposi's sarcoma

Renal cell carcinoma: treatment with recombinant interleukin-2 plus beta-interferon

Phase I evaluation of combination therapy with interleukin 2 and γ-interferon

A phase I study of recombinant interleukin 2 plus recombinant β-interferon

Hoarseness ; a unique clinical presentation for renal cell carcinoma

Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancer

Reversible neurotoxicity due to oral acyclovir in a patient with chronic lymphocytic leukemia

Phase I study of sequentially administered recombinant tumor necrosis factor and recombinant interleukin-2

The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: cognitive function and performance status. North Central Cancer Treatment Group

Kaposi sarcoma and alpha-interferon therapy

Hemorrhagic Gastritis as a New Dose-Limiting Toxicity of Recombinant Tumor Necrosis Factor

A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinoma

A Phase I study of WR-2721 in combination with total body irradiation (TBI) in patients with refractory lymphoid malignancies

Metastatic extramedullary plasmacytoma: A case report and review of the literature of a rare pseudocarcinoma

Suchergebnisse filtern